Agency has said it could authorize a vaccine for younger children in a matter of weeks after receipt of trial data
mRNA-1273 Continues to Be Efficacious at Five Months
Vaccine efficacy was 93.2 percent for preventing COVID-19 illness, 98.2 percent for preventing severe COVID-19
Highest Parental COVID-19 Vaccine Hesitancy Seen Among Most Impacted
Black parents and those of publicly insured children show greatest vaccine hesitancy
Pfizer to Ask FDA Soon for Approval of Its COVID-19 Vaccine for Younger Children
Right now, COVID-19 vaccines are only approved for children 12 years and older
Vaccines Effective in Preventing Symptomatic COVID-19 in Health Care Workers
Findings seen even for those at risk for severe disease and racial and ethnic groups disproportionately affected by the pandemic
Schizophrenia Tied to Higher Risk for Severe COVID-19
Risk higher despite lower infection risk and regardless of sociodemographic and medical factors
CDC Director Issues Interim 3rd COVID-19 Vaccine Guidance
The 19th Director of the U.S. CDC, Rochelle P. Walensky, M.D., M.P.H., issued a statement today endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in specific populations.
Dr. Walensky also recommended a booster dose for those in high-risk occupational and institutional settings.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 20 to 24, 2021. This …
Antibodies ID’d in Neonates of Women Vaccinated Against COVID-19
All 36 neonates had high levels of anti-S IgG; in 34 of 36 neonates, levels exceeded 250 U/mL
Past Trauma Tied to Worse Mental Health During Pandemic for Aging Women
History of childhood abuse or intimate partner violence linked to greater depression, anxiety, and sleep problems during COVID-19 pandemic